주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-03-29 17:06 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Policy
목록
(
총 :
1,137 )
기사목록 보기 형태
제목형
요약형
포토형
‘No change in quarantine system despite inflows of most contagious, immune-avoiding Omicron subvariant’
Lee Han-soo
2022.07.15 17:56
Korea confirms 1st case of BA.2.75 -- most infectious and immune-avoiding Omicron subvariant
Lee Han-soo
2022.07.14 19:20
Despite another Covid-19 wave, Korea will not reinstate social distancing system
Lee Han-soo
2022.07.13 18:40
Rights watchdog recommends more telemedicine for inmates
Song Soo-youn
2022.07.13 14:05
Pharma industry lambastes little support for API sector
Kim Chan-hyuk
2022.07.13 11:49
Korea considers expanding 2nd booster shot to 50s
Lee Han-soo
2022.07.11 18:00
Regulator bans import of GSK’s disposable biopsy punch for 3 months
Lee Han-soo
2022.07.11 17:04
Government to distribute Omicron subvariants to support vaccine, treatment development
Kim Ju-yeon
2022.07.11 15:19
Father begs new breast cancer drug Enhertu approval for his daughter
Kim Yun-mi
2022.07.11 13:57
Korea confirms Covid-19 resurge, stresses need for alertness
Lee Han-soo
2022.07.08 17:05
Korea’s daily Covid-19 cases double that of a week ago amid concerns over 6th wave
Lee Han-soo
2022.07.07 18:38
Government ends monitoring for cold medicines as supply stabilizes
Kim Chan-hyuk
2022.07.07 11:55
처음
이전
이전
이전
51
52
53
54
55
56
57
58
59
60
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기